Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Buggert

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Cell Reports|December 21, 2017
HIV-Specific CD8<sup>+</sup> T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid TissueMorgan A Reuter, Perla M Del Rio Estrada, Marcus Buggert, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Plos Pathogens|August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV InfectionKorey R Demers, George Makedonas, Marcus Buggert, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Science Immunology|July 5, 2020
TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cellsTakuya Sekine, André Perez-Potti, Son Nguyen, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2018
The CD4<sup>-</sup>CD8<sup>-</sup> MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8<sup>+</sup> MAIT cell poolJoana Dias, Caroline Boulouis, Jean-Baptiste Gorin, et al.
Cell Host & Microbe|January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variantThomas R Müller, Yu Gao, Jinghua Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Cell Reports|December 21, 2017
HIV-Specific CD8<sup>+</sup> T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid TissueMorgan A Reuter, Perla M Del Rio Estrada, Marcus Buggert, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Plos Pathogens|August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV InfectionKorey R Demers, George Makedonas, Marcus Buggert, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Science Immunology|July 5, 2020
TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cellsTakuya Sekine, André Perez-Potti, Son Nguyen, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2018
The CD4<sup>-</sup>CD8<sup>-</sup> MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8<sup>+</sup> MAIT cell poolJoana Dias, Caroline Boulouis, Jean-Baptiste Gorin, et al.
Cell Host & Microbe|January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variantThomas R Müller, Yu Gao, Jinghua Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.
Pageof 13